Selected Publications
Electronic Prior Authorization for Prescription Drugs — Challenges and Opportunities for Reform
Jing Luo, M.D., M.P.H., and Walid F. Gellad, M.D., M.P.H.
NEJM, March 4, 2023
Reforming Reimbursement for the US Food and Drug Administration's Accelerated Approval Program to Support State Medicaid Programs
Rachel E. Sachs, JD, MPH; Julie M. Donohue, PhD; Stacie B. Dusetzina, PhD
JAMA Health Forum, November 18, 2022
The Inflation Reduction Act: One step closer to pharmacoequity?
Utibe R. Essien
STAT, August 19, 2022
Myocarditis and pericarditis risk after covid-19 vaccination
Jing Luo & Walid F Gellad
The BMJ, July 13, 2022
Accelerated Approval — Taking the FDA’s Concerns Seriously
Rachel E. Sachs, J.D., M.P.H., Julie M. Donohue, Ph.D., and Stacie B. Dusetzina, Ph.D.
NEJM, July 6, 2022
Trends in Opioid Prescribing by General Dentists and Dental Specialists in the U.S., 2012–2019
Connie H. Yan PharmD, PhD, Todd A. Lee PharmD, PhD, Lisa K. Sharp PhD, Colin C. Hubbard PhD, Charlesnika T. Evans PhD, MPH, Gregory S. Calip PharmD, MPH, PhD, Susan A. Rowan DDS, MS, Jessina C. McGregor PhD, Walid F. Gellad MD, MPH, Katie J. Suda PharmD, MS
American Journal of Preventive Medicine, February 26, 2022
2023 Publications
A retrospective cohort study of patient-reported urinary tract infection signs and symptoms among individuals with neurogenic bladder
Marissa Wirth, Katie J Suda, Stephen P Burns, Frances M Weaver, Eileen Collins, Nasia Safdar, Rebecca Kartje, Charlesnika T Evans, Margaret A Fitzpatrick
American Journal of Physical Medicine and Rehabilitation, March 15, 2023
Electronic Prior Authorization for Prescription Drugs — Challenges and Opportunities for Reform
Jing Luo, M.D., M.P.H., and Walid F. Gellad, M.D., M.P.H.
NEJM, March 4, 2023
RE: Maxillofacial Surgeons Beware: Some AHA "Moderate Risk" Patients Develop Endocarditis After Exodontia
Katie J Suda, Bernard J Costello, Susan E Sutherland, Elsbeth Kalenderian
Journal of Oral and Maxillofacial Surgery, March 2023
Deprescribing Strategies for Opioids and Benzodiazepines with Emphasis on Concurrent Use: A Scoping Review
Yanning Wang, Debbie L Wilson, Deanna Fernandes, Lauren E Adkins, Ashley Bantad, Clint Copacia, Nilay Dharma, Pei-Lin Huang, Amanda Joseph, Tae Woo Park, Jeffrey Budd, Senthil Meenrajan, Frank A Orlando, John Pennington, Siegfried Schmidt, Ronald Shorr, Constance R Uphold, Wei-Hsuan Lo-Ciganic
Journal of Clinical Medicine, February 23, 2023
Value assessment of deprescribing interventions: Suggestions for improvement
Anna Hung, Jinjiao Wang, Frank Moriarty, Veena Manja, Tesfahun Eshetie, Henok Getachew Tegegn, Timothy S Anderson, Thomas R Radomski, Michael A Steinman
Journal of the American Geriatrics Society, February 21, 2023
Adverse outcomes associated with opioid prescription by dentists in the Veterans Health Administration: A national cross-sectional study from 2015 to 2018
Pooja A SolankI, Colin C Hubbard, Linda Poggensee, Charlesnika T Evans, Katie J Suda
Journal of Public Health Dentistry, February 17, 2023
COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data
Inmaculada Hernandez, Meiqi He, Jingchuan Guo, Mina Tadrous, Nico Gabriel, Gretchen Swabe, Walid F. Gellad, Utibe R. Essien, Samir Saba, Emelia J. Benjamin, Jared W. Magnani
PLoS One, February 2, 2023
Effects of the July 2018 worldwide valsartan recall and shortage on global trends in antihypertensive medication use: a time-series analysis in 83 countries
Yuna Choi, Araniy Santhireswaran, Cherry Chu, Katie J Suda, Inma Hernandez, Jared W Magnani, Mina Tadrous
BMJ Open, January 27, 2023
Pre-Paid Phone Distribution: A Tool for Improving Healthcare Engagement for People with Substance Use Disorder
Alyssa F Peterkin, Raagini Jawa, Kalil Menezes, Jacqueline You, Howard Cabral, Glorimar Ruiz-Mercado, Tae Woo Park, Jessica Kehoe, Jessica L Taylor, Zoe M Weinstein
Substance Use & Misuse, January 25, 2023
Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design
Payel Jhoom Roy, Katherine Callaway Kim, Katie Suda, Jing Luo, Xiaoming Wang, Donna Olejniczak, Jane M Liebschutz
Drug and Alcohol Dependence Reports, January 25, 2023
Recreational cannabis and opioid distribution
Shyam Raman, Johanna Catherine Maclean, W. David Bradford, Coleman Drake
Health Economics, January 18, 2023
Analysis by Gender and Race and Ethnicity of Reviewers and Awardees for Intramural Research Funding in the Veterans Health Administration
Taylor L. Boyer, MPH; Utibe R. Essien, MD, MPH; Terrence M. A. Litam, MHA; Leslie R. M. Hausmann, PhD; Katie J. Suda, PharmD, MS
JAMA Network Open, January 18, 2023
Real-world weight-loss effectiveness of glucagon-like peptide-1 agonists among patients with type 2 diabetes: A retrospective cohort study
Gretchen E. White, Ingrid Shu, David Rometo, Jon Arnold, Mary Korytkowski, Jing Luo
Obesity, January 9, 2023
Prevalence of testing for HIV, HBV, and HCV among Medicaid enrollees treated with medications for opioid use disorder in 11 states, 2016-2019
Katherine Ahrens, PhD, Michael Sharbaugh, MPH, Marian P Jarlenski, PhD, Lu Tang, PhD, Lindsay Allen, PhD, Anna E Austin, PhD, Andrew J Barnes, PhD, Marguerite E Burns, PhD, Sarah Clark, MPH, Kara Zivin, PhD, MS, MA, Aimee Mack, MPH, Gilbert Liu, MD, MS, Shamis Mohamoud, MA, Mary Joan McDuffie, MA, Lindsey Hammerslag, PhD, Adam J Gordon, MD, MPH, Julie M Donohue, PhD, the Writing Committee for MODRN
Clinical Infectious Diseases, January 3, 2023